BioCentury
ARTICLE | Company News

Galapagos, Boehringer Ingelheim deal

April 22, 2013 7:00 AM UTC

Galapagos' Argenta Discovery Ltd. service division will apply its respiratory drug discovery services for an undisclosed target from Boehringer. Argenta said Boehringer has rights to the resulting IP...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article